New On Robinhood

Dyne Therapeutics

$20.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.38 (+1.88%) As of 2:22 PM UTC pre-market

Why Robinhood?

You can buy or sell DYN and other stocks, options, and ETFs commission-free!

About DYN

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA. The listed name for DYN is Dyne Therapeutics, Inc. Common Stock.

CEO
Joshua T. Brumm
Employees
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
1.23B
Price-Earnings Ratio
Dividend Yield
Average Volume
734.51K
High Today
$21.94
Low Today
$20.20
Open Price
$21.92
Volume
1.64M
52 Week High
$32.32
52 Week Low
$15.60

Collections

DYN Earnings

-$2.01
-$1.34
-$0.67
$0.00
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, Pre-Market

You May Also Like

STAR-G
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure